The global peptide microarray market, valued at USD 794.3 million in 2022, is expected to reach USD 1120.9 million by 2030, expanding at a compound annual growth rate (CAGR) of 4.4% from 2023 to 2030. This growth underscores the increasing utilization of peptide microarrays in drug discovery, diagnostics, and proteomics research, driven by advancements in biotechnology and the growing...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian